Target Selection

Target selection remains one of the most important decisions and investments that companies make in the drug discovery process. Pursuing the wrong target can waste significant amounts of time and money, and eventually result in failure of the program. To ensure downstream success, targets must be accurately identified and thoroughly validated. Target validation ensures that engagement of the target has potential therapeutic benefit and, along with target identification, is a critical step in the drug development process. A strong link between the target and disease also needs to be demonstrated.

When combined, our in vitro and in vivo technologies provide data on the biological entity associated with the disease of interest and whether appropriate modulation of the target impacts disease in a consistent manner to make the most accurate prediction of target relevance in human disease.

Key benefits include:

• Precision in target identification enhances drug discovery
• Comprehensive validation solutions for reliable targets
• Cutting-edge technologies for biomarker discovery
• High-throughput screening for efficient target selection
• Advanced molecular imaging for detailed biological insights